73 results on '"Reiner, Thomas"'
Search Results
2. Development and Validation of Nerve-Targeted Bacteriochlorin Sensors
- Author
-
Hernández-Gil, Javier, Chow, Chun Yuen, Chatras, Hugo, de Souza França, Paula Demétrio, Samuels, Zachary V., Cornejo, Mike, King, Glenn F., Lewis, Jason S., Reiner, Thomas, and Gonzales, Junior
- Abstract
We report an innovative approach to producing bacteriochlorins (bacs) via formal cycloaddition by subjecting a porphyrin to a trimolecular reaction. Bacs are near-infrared probes with the intrinsic ability to serve in multimodal imaging. However, despite their ability to fluoresce and chelate metal ions, existing bacs have thus offered limited ability to label biomolecules for target specificity or have lacked chemical purity, limiting their use in bio-imaging. In this work, bacs allowed a precise and controlled appending of clickable linkers, lending the porphyrinoids substantially more chemical stability, clickability, and solubility, rendering them more suitable for preclinical investigation. Our bac probes enable the targeted use of biomolecules in fluorescence imaging and Cerenkov luminescence for guided intraoperative imaging. Bacs’ capacity for chelation provides opportunities for use in non-invasive positron emission tomography/computed tomography. Herein, we report the labeling of bacs with Hs1a, a (NaV1.7)-sodium-channel-binding peptide derived from the Chinese tarantula Cyriopagopus schmidtito yield Bac-Hs1a and radiolabeled Hs1a, which shuttles our bac sensor(s) to mouse nerves. In vivo, the bac sensor allowed us to observe high signal-to-background ratios in the nerves of animals injected with fluorescent Bac-Hs1a and radiolabeled Hs1a in all imaging modes. This study demonstrates that Bac-Hs1a and [64Cu]Cu-Bac-Hs1a accumulate in peripheral nerves, providing contrast and utility in the preclinical space. For the chemistry and bio-imaging fields, this study represents an exciting starting point for the modular manipulation of bacs, their development and use as probes for diagnosis, and their deployment as formidable multiplex nerve-imaging agents for use in routine imaging experiments.
- Published
- 2023
- Full Text
- View/download PDF
3. A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer.
- Author
-
Hank, Thomas, Hinz, Ulf, Reiner, Thomas, Malleo, Giuseppe, König, Anna-Katharina, Maggino, Laura, Marchegiani, Giovanni, Kaiser, Jörg, Paiella, Salvatore, Binco, Alessandra, Salvia, Roberto, Hackert, Thilo, Bassi, Claudio, Büchler, Markus W., and Strobel, Oliver
- Abstract
Objective: The aim of this study was to develop and validate a pretreatment prognostic score in pancreatic cancer (PDAC). Background: Pretreatment prognostication in PDAC is important for treatment decisions but remains challenging. Available prognostic tools are derived from selected cohorts of patients who underwent resection, excluding up to 20% of patients with exploration only, and do not adequately reflect the pretreatment scenario. Methods: Patients undergoing surgery for PDAC in Heidelberg from July 2006 to June 2014 were identified from a prospective database. Pretreatment parameters were extracted from the database and the laboratory information system. Parameters independently associated with overall survival by uni- and multivariable analyses were used to build a prognostic score. A contemporary cohort from Verona was used for external validation. Results: In 1197 patients, multiple pretreatment parameters were associated with overall survival by univariable analyses. American Society of Anesthesiology classification, carbohydrate antigen 19-9 (CA19-9), carcinoembryonic antigen, C-reactive protein, albumin, and platelet count were independently associated with survival and were used to create the Heidelberg Prognostic Pancreatic Cancer (HELPP)-score. The HELPP-score was closely associated with overall survival (median survival between 31.3 and 4.8 months; 5-year survival rates between 35% and 0%) and was able to stratify survival in subgroups with or without resection as well as in CA19-9 nonsecretors. In the resected subgroup the HELPP-score stratified survival independently of pathological prognostic factors. The HELPP-score was externally validated and was superior to CA19-9 in both the development and validation cohorts. Conclusion: The HELPP-score is a readily available prognostic tool based on pretreatment routine parameters to stratify survival in PDAC independently of resection status and pathological tumor stage. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer
- Author
-
Hank, Thomas, Hinz, Ulf, Reiner, Thomas, Malleo, Giuseppe, König, Anna-Katharina, Maggino, Laura, Marchegiani, Giovanni, Kaiser, Jörg, Paiella, Salvatore, Binco, Alessandra, Salvia, Roberto, Hackert, Thilo, Bassi, Claudio, Büchler, Markus W., and Strobel, Oliver
- Published
- 2022
- Full Text
- View/download PDF
5. Inhibition of Microtubule Dynamics in Cancer Cells by Indole-Modified Latonduine Derivatives and Their Metal Complexes.
- Author
-
Wittmann, Christopher, Sivchenko, Anastasiia S., Bacher, Felix, Tong, Kelvin K. H., Guru, Navjot, Wilson, Thomas, Gonzales, Junior, Rauch, Hartmut, Kossatz, Susanne, Reiner, Thomas, Babak, Maria V., and Arion, Vladimir B.
- Published
- 2022
- Full Text
- View/download PDF
6. Inhibition of Microtubule Dynamics in Cancer Cells by Indole-Modified Latonduine Derivatives and Their Metal Complexes
- Author
-
Wittmann, Christopher, Sivchenko, Anastasiia S., Bacher, Felix, Tong, Kelvin K. H., Guru, Navjot, Wilson, Thomas, Gonzales, Junior, Rauch, Hartmut, Kossatz, Susanne, Reiner, Thomas, Babak, Maria V., and Arion, Vladimir B.
- Abstract
Indolo[2,3-d]benzazepines (indololatonduines) are rarely discussed in the literature. In this project, we prepared a series of novel indololatonduine derivatives and their RuIIand OsIIcomplexes and investigated their microtubule-targeting properties in comparison with paclitaxel and colchicine. Compounds were fully characterized by spectroscopic techniques (1H NMR and UV–vis), ESI mass-spectrometry, and X-ray crystallography, and their purity was confirmed by elemental analysis. The stabilities of the compounds in DMSO and water were confirmed by 1H and 13C NMR and UV–vis spectroscopy. Novel indololatonduines demonstrated anticancer activity in vitroin a low micromolar concentration range, while their coordination to metal centers resulted in a decrease of cytotoxicity. The preliminary in vivoactivity of the RuIIcomplex was investigated. Fluorescence staining and in vitrotubulin polymerization assays revealed the prepared compounds to have excellent microtubule-destabilizing activities, even more potent than the well-known microtubule-destabilizing agent colchicine.
- Published
- 2022
- Full Text
- View/download PDF
7. Bimodal Imaging of Mouse Peripheral Nerves with Chlorin Tracers.
- Author
-
Gonzales, Junior, Hernández-Gil, Javier, Wilson, Thomas C., Adilbay, Dauren, Cornejo, Mike, Demétrio de Souza Franca, Paula, Guru, Navjot, Schroeder, Christina I., King, Glenn F., Lewis, Jason S., and Reiner, Thomas
- Published
- 2021
- Full Text
- View/download PDF
8. PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models
- Author
-
Wilson, Thomas, Pirovano, Giacomo, Xiao, Gu, Samuels, Zachary, Roberts, Sheryl, Viray, Tara, Guru, Navjot, Zanzonico, Pat, Gollub, Marc, Pillarsetty, Naga Vara Kishore, Reiner, Thomas, and Bargonetti, Jill
- Abstract
Despite Auger electrons being highly appealing due to their short-range and high linear energy transfer to surrounding tissues, the progress in the field has been limited due to the challenge in delivering a therapeutic dose within the close proximity of cancer cell’s DNA. Here, we demonstrate that the PARP inhibitor 123I-MAPi is a viable agent for the systemic administration and treatment of p53 mutant cancers. Significantly, minimal off-site toxicity was observed in mice administered with up to 74 MBq of 127I-PARPi. Taken together, these results lay the foundation for future clinical evaluation and broader preclinical investigations. By harnessing the scaffold of the PARP inhibitor Olaparib, we were able to deliver therapeutic levels of Auger radiation to the site of human colorectal cancer xenograft tumors after systemic administration. In-depth toxicity studies analyzed blood chemistry levels and markers associated with specific organ toxicity. Finally, p53+/+and p53–/–human colorectal cancer cell lines were evaluated for the ability of 123I-MAPi to induce tumor growth delay. Toxicity studies demonstrate that both 123I-MAPi and its stable isotopologue, 127I-PARPi, have no significant off-site toxicity when administered systemically. Analysis following 123I-MAPi treatment confirmed its ability to induce DNA damage at the site of xenograft tumors when administered systemically. Finally, we demonstrate that 123I-MAPi generates a therapeutic response in p53–/–, but not p53+/+, subcutaneous xenograft tumors in mouse models. Taken together, these results represent the first example of a PARP Auger theranostic agent capable of delivering a therapeutic dose to xenograft human colorectal cancer tumors upon systemic administration without causing significant toxicity to surrounding mouse organs. Moreover, it suggests that a PARP Auger theranostic can act as a targeted therapeutic for cancers with mutated p53 pathways. This landmark goal paves the way for clinical evaluation of 123I-MAPi for pan cancer therapeutics.
- Published
- 2021
- Full Text
- View/download PDF
9. Sensors and Inhibitors for the Detection of Ataxia Telangiectasia Mutated (ATM) Protein Kinase
- Author
-
Huang, Cien, Filippone, Nina R., Reiner, Thomas, and Roberts, Sheryl
- Abstract
Recruitment and activation of the ataxia telangiectasia mutated (ATM) kinase regulate multiple cell-cycle checkpoints relevant to complex biological events like DNA damage repair and apoptosis. Molecularly specific readouts of ATM using protein assays, fluorescence, or radiolabeling have advanced significantly over the past few years. This Review covers the molecular imaging techniques that enable the visualization of ATM—from traditional quantitative protein assays to the potential use of ATM inhibitors to generate new imaging agents to interrogate ATM. We are confident that molecular imaging coupled with advanced technologies will play a pivotal role in visualizing and understanding the biology of ATM and accelerate its applications in the diagnosis and monitoring of disease, including radiation therapy and patient stratification.
- Published
- 2021
- Full Text
- View/download PDF
10. Imaging Cardiovascular and Lung Macrophages With the Positron Emission Tomography Sensor 64Cu-Macrin in Mice, Rabbits, and Pigs.
- Author
-
Nahrendorf, Matthias, Hoyer, Friedrich Felix, Meerwaldt, Anu E., van Leent, Mandy M. T., Senders, Max L., Calcagno, Claudia, Robson, Philip M., Soultanidis, George, Pérez-Medina, Carlos, Teunissen, Abraham J. P., Toner, Yohana C., Ishikawa, Kiyotake, Fish, Kenneth, Sakurai, Ken, van Leeuwen, Esther M., Klein, Emma D., Sofias, Alexandros Marios, Reiner, Thomas, Rohde, David, and Aguirre, Aaron D.
- Abstract
BACKGROUND: Macrophages, innate immune cells that reside in all organs, defend the host against infection and injury. In the heart and vasculature, inflammatory macrophages also enhance tissue damage and propel cardiovascular diseases. METHODS: We here use in vivo positron emission tomography (PET) imaging, flow cytometry, and confocal microscopy to evaluate quantitative noninvasive assessment of cardiac, arterial, and pulmonary macrophages using the nanotracer
64 Cu-Macrin—a 20-nm spherical dextran nanoparticle assembled from nontoxic polyglucose. RESULTS: PET imaging using64 Cu-Macrin faithfully reported accumulation of macrophages in the heart and lung of mice with myocardial infarction, sepsis, or pneumonia. Flow cytometry and confocal microscopy detected the near-infrared fluorescent version of the nanoparticle (VT680Macrin) primarily in tissue macrophages. In 5-day-old mice,64 Cu-Macrin PET imaging quantified physiologically more numerous cardiac macrophages. Upon intravenous administration of64 Cu-Macrin in rabbits and pigs, we detected heightened macrophage numbers in the infarcted myocardium, inflamed lung regions, and atherosclerotic plaques using a clinical PET/magnetic resonance imaging scanner. Toxicity studies in rats and human dosimetry estimates suggest that64 Cu-Macrin is safe for use in humans. CONCLUSIONS: Taken together, these results indicate64 Cu-Macrin could serve as a facile PET nanotracer to survey spatiotemporal macrophage dynamics during various physiological and pathological conditions.64 Cu-Macrin PET imaging could stage inflammatory cardiovascular disease activity, assist disease management, and serve as an imaging biomarker for emerging macrophage-targeted therapeutics. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
11. Tumor Targeting by αvβ3‑Integrin-Specific Lipid Nanoparticles Occurs via Phagocyte Hitchhiking.
- Author
-
Sofias, Alexandros Marios, Toner, Yohana C., Meerwaldt, Anu E., van Leent, Mandy M. T., Soultanidis, Georgios, Elschot, Mattijs, Gonai, Haruki, Grendstad, Kristin, Flobak, Åsmund, Neckmann, Ulrike, Wolowczyk, Camilla, Fisher, Elizabeth L., Reiner, Thomas, Davies, Catharina de Lange, Bjørkøy, Geir, Teunissen, Abraham J. P., Ochando, Jordi, Pérez-Medina, Carlos, Mulder, Willem J. M., and Hak, Sjoerd
- Published
- 2020
- Full Text
- View/download PDF
12. Fluorescence Imaging of Peripheral Nerves by a Nav1.7-Targeted Inhibitor Cystine Knot Peptide.
- Author
-
Gonzales, Junior, Demetrio de Souza Franca, Paula, Jiang, Yan, Pirovano, Giacomo, Kossatz, Susanne, Guru, Navjot, Yarilin, Dimitry, Agwa, Akello J., Schroeder, Christina I., Patel, Snehal G., Ganly, Ian, King, Glenn F., and Reiner, Thomas
- Published
- 2019
- Full Text
- View/download PDF
13. Bimodal Imaging of Mouse Peripheral Nerves with Chlorin Tracers
- Author
-
Gonzales, Junior, Hernández-Gil, Javier, Wilson, Thomas C., Adilbay, Dauren, Cornejo, Mike, Demétrio de Souza Franca, Paula, Guru, Navjot, Schroeder, Christina I., King, Glenn F., Lewis, Jason S., and Reiner, Thomas
- Abstract
Almost 17 million Americans have a history of cancer, a number expected to reach over 22 million by 2030. Cancer patients often undergo chemotherapy in the form of antineoplastic agents such as cis-platin and paclitaxel. Though effective, these agents can induce debilitating side effects; the most common neurotoxic effect, chemotherapy-induced peripheral neuropathy (CIPN), can endure long after treatment ends. Despite the widespread and chronic nature of the dysfunction, no tools exist to quantitatively measure chemotherapy-induced peripheral neuropathy. Such a tool would not only benefit patients but their stratification could also save significant financial and social costs associated with neuropathic pain. In our first step toward addressing this unmet clinical need, we explored a novel dual approach to localize peripheral nerves: Cerenkov luminescence imaging (CLI) and fluorescence imaging (FI). Our approach revolves around the targeting and imaging of voltage-gated sodium channel subtype NaV1.7, highly expressed in peripheral nerves from both harvested human and mouse tissues. For the first time, we show that Hsp1a, a radiolabeled NaV1.7-selective peptide isolated from Homoeommaspec. Peru, can serve as a targeted vector for delivering a radioactive sensor to the peripheral nervous system. In situ, we observe high signal-to-noise ratios in the sciatic nerves of animals injected with fluorescently labeled Hsp1a and radiolabeled Hsp1a. Moreover, confocal microscopy on fresh nerve tissue shows the same high ratios of fluorescence, corroborating our in vivoresults. This study indicates that fluorescently labeled and radiolabeled Hsp1a tracers could be used to identify and demarcate nerves in a clinical setting.
- Published
- 2021
- Full Text
- View/download PDF
14. Tumor Targeting by αvβ3-Integrin-Specific Lipid Nanoparticles Occurs viaPhagocyte Hitchhiking
- Author
-
Sofias, Alexandros Marios, Toner, Yohana C., Meerwaldt, Anu E., van Leent, Mandy M. T., Soultanidis, Georgios, Elschot, Mattijs, Gonai, Haruki, Grendstad, Kristin, Flobak, Åsmund, Neckmann, Ulrike, Wolowczyk, Camilla, Fisher, Elizabeth L., Reiner, Thomas, Davies, Catharina de Lange, Bjørkøy, Geir, Teunissen, Abraham J. P., Ochando, Jordi, Pérez-Medina, Carlos, Mulder, Willem J. M., and Hak, Sjoerd
- Abstract
Although the first nanomedicine was clinically approved more than two decades ago, nanoparticles’ (NP) in vivobehavior is complex and the immune system’s role in their application remains elusive. At present, only passive-targeting nanoformulations have been clinically approved, while more complicated active-targeting strategies typically fail to advance from the early clinical phase stage. This absence of clinical translation is, among others, due to the very limited understanding for in vivotargeting mechanisms. Dynamic in vivophenomena such as NPs’ real-time targeting kinetics and phagocytes’ contribution to active NP targeting remain largely unexplored. To better understand in vivotargeting, monitoring NP accumulation and distribution at complementary levels of spatial and temporal resolution is imperative. Here, we integrate in vivopositron emission tomography/computed tomography imaging with intravital microscopy and flow cytometric analyses to study αvβ3-integrin-targeted cyclic arginine-glycine-aspartate decorated liposomes and oil-in-water nanoemulsions in tumor mouse models. We observed that ligand-mediated accumulation in cancerous lesions is multifaceted and identified “NP hitchhiking” with phagocytes to contribute considerably to this intricate process. We anticipate that this understanding can facilitate rational improvement of nanomedicine applications and that immune cell–NP interactions can be harnessed to develop clinically viable nanomedicine-based immunotherapies.
- Published
- 2020
- Full Text
- View/download PDF
15. Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging
- Author
-
Senders, Max L., Meerwaldt, Anu E., van Leent, Mandy M. T., Sanchez-Gaytan, Brenda L., van de Voort, Jan C., Toner, Yohana C., Maier, Alexander, Klein, Emma D., Sullivan, Nathaniel A. T., Sofias, Alexandros Marios, Groenen, Hannah, Faries, Christopher, Oosterwijk, Roderick S., van Leeuwen, Esther M., Fay, Francois, Chepurko, Elena, Reiner, Thomas, Duivenvoorden, Raphael, Zangi, Lior, Dijkhuizen, Rick M., Hak, Sjoerd, Swirski, Filip K., Nahrendorf, Matthias, Pérez-Medina, Carlos, Teunissen, Abraham J. P., Fayad, Zahi A., Calcagno, Claudia, Strijkers, Gustav J., and Mulder, Willem J. M.
- Abstract
Ischaemic heart disease evokes a complex immune response. However, tools to track the systemic behaviour and dynamics of leukocytes non-invasively in vivo are lacking. Here, we present a multimodal hot-spot imaging approach using an innovative high-density lipoprotein-derived nanotracer with a perfluoro-crown ether payload (19F-HDL) to allow myeloid cell tracking by 19F magnetic resonance imaging. The 19F-HDL nanotracer can additionally be labelled with zirconium-89 and fluorophores to detect myeloid cells by in vivo positron emission tomography imaging and optical modalities, respectively. Using our nanotracer in atherosclerotic mice with myocardial infarction, we observed rapid myeloid cell egress from the spleen and bone marrow by in vivo 19F-HDL magnetic resonance imaging. Concurrently, using ex vivo techniques, we showed that circulating pro-inflammatory myeloid cells accumulated in atherosclerotic plaques and at the myocardial infarct site. Our multimodality imaging approach is a valuable addition to the immunology toolbox, enabling the study of complex myeloid cell behaviour dynamically.
- Published
- 2020
- Full Text
- View/download PDF
16. Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall
- Author
-
Lobatto, Mark E., Binderup, Tina, Robson, Philip M., Giesen, Luuk F. P., Calcagno, Claudia, Witjes, Julia, Fay, Francois, Baxter, Samantha, Wessel, Chang Ho, Eldib, Mootaz, Bini, Jason, Carlin, Sean D., Stroes, Erik S. G., Storm, Gert, Kjaer, Andreas, Lewis, Jason S., Reiner, Thomas, Fayad, Zahi A., Mulder, Willem J. M., and Pérez-Medina, Carlos
- Abstract
Nanotherapy has recently emerged as an experimental treatment option for atherosclerosis. To fulfill its promise, robust noninvasive imaging approaches for subject selection and treatment evaluation are warranted. To that end, we present here a positron emission tomography (PET)-based method for quantification of liposomal nanoparticle uptake in the atherosclerotic vessel wall. We evaluated a modular procedure to label liposomal nanoparticles with the radioisotope zirconium-89 (89Zr). Their biodistribution and vessel wall targeting in a rabbit atherosclerosis model was evaluated up to 15 days after intravenous injection by PET/computed tomography (CT) and PET/magnetic resonance imaging (PET/MRI). Vascular permeability was assessed in vivousing three-dimensional dynamic contrast-enhanced MRI (3D DCE-MRI) and ex vivousing near-infrared fluorescence (NIRF) imaging. The 89Zr-radiolabeled liposomes displayed a biodistribution pattern typical of long-circulating nanoparticles. Importantly, they markedly accumulated in atherosclerotic lesions in the abdominal aorta, as evident on PET/MRI and confirmed by autoradiography, and this uptake moderately correlated with vascular permeability. The method presented herein facilitates the development of nanotherapy for atherosclerotic disease as it provides a tool to screen for nanoparticle targeting in individual subjects’ plaques.
- Published
- 2020
- Full Text
- View/download PDF
17. Smartphone epifluorescence microscopy for cellular imaging of fresh tissue in low-resource settings
- Author
-
Zhu, Wenbin, Pirovano, Giacomo, O’Neal, Patrick K., Gong, Cheng, Kulkarni, Nachiket, Nguyen, Christopher D., Brand, Christian, Reiner, Thomas, and Kang, Dongkyun
- Abstract
Disease diagnosis in low-resource settings can be challenging due to the lack of equipment and trained personnel required for histologic analysis. In this paper, we have developed a smartphone-based epifluorescence microscope (SeFM) for imaging fresh tissues at sub-cellular resolution. SeFM provides similar resolution and field of view (FOV) as those used during histologic analysis. The SeFM device achieved the lateral resolution of 0.57 µm and provided microscopy images over a sample area larger than 500 µm. The material cost was low, approximately $3,000. Preliminary images of human pancreatic tumor specimens clearly visualized cellular details. Quantitative analysis showed that using an excess dose of a chemotherapy drug significantly reduced the tumor-specific fluorescence signal, confirming the specificity of the drug and the detection potential of SeFM.
- Published
- 2020
18. Fluorescence Imaging of Peripheral Nerves by a Nav1.7-Targeted Inhibitor Cystine Knot Peptide
- Author
-
Gonzales, Junior, Demetrio de Souza Franca, Paula, Jiang, Yan, Pirovano, Giacomo, Kossatz, Susanne, Guru, Navjot, Yarilin, Dimitry, Agwa, Akello J., Schroeder, Christina I., Patel, Snehal G., Ganly, Ian, King, Glenn F., and Reiner, Thomas
- Abstract
Twenty million Americans suffer from peripheral nerve injury caused by trauma and medical disorders, resulting in a broad spectrum of potentially debilitating side effects. In one out of four cases, patients identify surgery as the root cause of their nerve injury. Particularly during tumor resections or after traumatic injuries, tissue distortion and poor visibility can challenge a surgeon’s ability to precisely locate and preserve peripheral nerves. Intuitively, surgical outcomes would improve tremendously if nerves could be highlighted using an exogeneous contrast agent. In clinical practice, however, the current standard of care—visual examination and palpation—remains unchanged. To address this unmet clinical need, we explored the expression of voltage-gated sodium channel Nav1.7 as an intraoperative marker for the peripheral nervous system. We show that expression of Nav1.7 is high in peripheral nerves harvested from both human and mouse tissue. We further show that modification of a Nav1.7-selective peptide, Hsp1a, can serve as a targeted vector for delivering a fluorescent sensor to the peripheral nervous system. Ex vivo, we observe a high signal-to-noise ratio for fluorescently labeled Hsp1a in both histologically prepared and fresh tissue. Using a surgical fluorescent microscope, we show in a simulated clinical scenario that the identification of mouse sciatic nerves is possible, suggesting that fluorescently labeled Hsp1a tracers could be used to discriminate nerves from their surrounding tissues in a routine clinical setting.
- Published
- 2019
- Full Text
- View/download PDF
19. Nanoemulsion-Based Delivery of Fluorescent PARP Inhibitors in Mouse Models of Small Cell Lung Cancer.
- Author
-
Gonzales, Junior, Kossatz, Susanne, Roberts, Sheryl, Pirovano, Giacomo, Brand, Christian, Pérez-Medina, Carlos, Donabedian, Patrick, de la Cruz, M. Jason, Mulder, Willem J. M., and Reiner, Thomas
- Published
- 2018
- Full Text
- View/download PDF
20. Bioorthogonal Masking of Circulating Antibody–TCO Groups Using Tetrazine-Functionalized Dextran Polymers
- Author
-
Meyer, Jan-Philip, Tully, Kathryn M., Jackson, James, Dilling, Thomas R., Reiner, Thomas, and Lewis, Jason S.
- Abstract
Pretargeting strategies have gained popularity for the in vivoimaging and therapy of cancer by combining antibodies with small molecule radioligands. Invivorecombination of both moieties can be achieved using the bioorthogonal inverse electron demand Diels–Alder (IEDDA) chemistry between tetrazine (Tz) and trans-cyclooctene (TCO). An issue that arises with pretargeting strategies is that while part of the antibody dose accumulates at antigen-expressing tumor tissue, there is a significant portion of the injected antibody that remains in circulation, causing a reduction in target-to-background ratios. Herein, we report the development of a novel TCO scavenger, the masking agent DP–Tz. DP–Tz is based on Tz-modified dextran polymers (DP, MW = 0.5–2 MDa). Large dextran polymers were reported to exhibit low penetration of tumor vasculature and appeared nontoxic, nonimmunogenic, and easily modifiable. Our newly developed masking agent deactivates the remaining TCO-moieties on the circulating mAbs yet does not impact the tumor uptake of the Tz-radioligand. In pretargeting studies utilizing a 68Ga-labeled tetrazine radioligand ([68Ga]Ga-NOTA-PEG11-tetrazine), DP–Tz constructs (Tz/DP ratios of 62–254) significantly increased TTB ratios from 0.8 ± 0.3 (control cohorts) to up to 5.8 ± 2.3 at 2 h postinjection. Tumor tissue delineation in PET imaging experiments employing DP–Tz is significantly increased compared to control. Uptake values of other significant organs, such as heart, lungs, pancreas, and stomach, were decreased on average by 2-fold when using DP–Tz. Overall, pretargeting experiments utilizing DP–Tz showed significantly improved tumor delineation, enhanced PET image quality, and reduced uptake in vital organs. We believe that this new masking agent is a powerful new addition to the IEDDA-based pretargeting tool box and, due to its properties, an excellent candidate for clinical translation.
- Published
- 2024
- Full Text
- View/download PDF
21. Positron-Emission Tomographic Imaging of a Fluorine 18–Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient–Derived Xenografts
- Author
-
Laird, James, Lok, Benjamin H., Carney, Brandon, Kossatz, Susanne, de Stanchina, Elisa, Reiner, Thomas, Poirier, John T., and Rudin, Charles M.
- Abstract
Inhibitors of poly-(ADP)-ribose polymerase (PARP) are promising therapeutics for SCLC. We tested whether PARP inhibitor (PARPi) target engagement as measured by a fluorine 18–radiolabeled PARPi ([18F]PARPi) has the potential to predict drug efficacy in vivo.
- Published
- 2019
- Full Text
- View/download PDF
22. Smartphone-based epifluorescence microscope for fresh tissue imaging
- Author
-
Amelink, Arjen, Nadkarni, Seemantini K., Zhu, Wenbin, Pirovano, Giacomo, Gong, Cheng, Kulkarni, Nachiket, Nguyen, Christopher David, Brand, Christian, Reiner, Thomas, and Kang, Dongkyun
- Published
- 2019
- Full Text
- View/download PDF
23. Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging.
- Author
-
Francois Fay, Hansen, Line, Hectors, Stefanie J. C. G., Sanchez-Gaytan, Brenda L., Yiming Zhao, Jun Tang, Munitz, Jazz, Alaarg, Amr, Braza, Mounia S., Gianella, Anita, Aaronson, Stuart A., Reiner, Thomas, Kjems, Jørgen, Langer, Robert, Hoeben, Freek J. M., Janssen, Henk M., Calcagno, Claudia, Strijkers, Gustav J., Fayad, Zahi A., and Pérez-Medina, Carlos
- Published
- 2017
- Full Text
- View/download PDF
24. Nanoemulsion-Based Delivery of Fluorescent PARP Inhibitors in Mouse Models of Small Cell Lung Cancer
- Author
-
Gonzales, Junior, Kossatz, Susanne, Roberts, Sheryl, Pirovano, Giacomo, Brand, Christian, Pérez-Medina, Carlos, Donabedian, Patrick, de la Cruz, M. Jason, Mulder, Willem J. M., and Reiner, Thomas
- Abstract
The preclinical potential of many diagnostic and therapeutic small molecules is limited by their rapid washout kinetics and consequently modest pharmacological performances. In several cases, these could be improved by loading the small molecules into nanoparticulates, improving blood half-life, in vivouptake and overall pharmacodynamics. In this study, we report a nanoemulsion (NE) encapsulated form of PARPi-FL. As a proof of concept, we used PARPi-FL, which is a fluorescently labeled sensor for olaparib, a FDA-approved small molecule inhibitor of the nuclear enzyme poly(ADP-ribose)polymerase 1 (PARP1). Encapsulated PARPi-FL showed increased blood half-life, and delineated subcutaneous xenografts of small cell lung cancer (SCLC), a fast-progressing disease where efficient treatment options remain an unmet clinical need. Our study demonstrates an effective method for expanding the circulation time of a fluorescent PARP inhibitor, highlighting the pharmacokinetic benefits of nanoemulsions as nanocarriers and confirming the value of PARPi-FL as an imaging agent targeting PARP1 in small cell lung cancer.
- Published
- 2018
- Full Text
- View/download PDF
25. Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.
- Author
-
Cook, Brendon E., Adumeau, Pierre, Membreno, Rosemery, Carnazza, Kathryn E., Brand, Christian, Reiner, Thomas, Agnew, Brian J., Lewis, Jason S., and Zeglis, Brian M.
- Published
- 2016
- Full Text
- View/download PDF
26. 18F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.
- Author
-
Meyer, Jan-Philip, Houghton, Jacob L., Kozlowski, Paul, Abdel-Atti, Dalya, Reiner, Thomas, Kishore Pillarsetty, Naga Vara, Scholz, Wolfgang W., Zeglis, Brian M., and Lewis, Jason S.
- Published
- 2016
- Full Text
- View/download PDF
27. Measurement of drug-target engagement in live cells by two-photon fluorescence anisotropy imaging
- Author
-
Vinegoni, Claudio, Fumene Feruglio, Paolo, Brand, Christian, Lee, Sungon, Nibbs, Antoinette E, Stapleton, Shawn, Shah, Sunil, Gryczynski, Ignacy, Reiner, Thomas, Mazitschek, Ralph, and Weissleder, Ralph
- Abstract
The ability to directly image and quantify drug-target engagement and drug distribution with subcellular resolution in live cells and whole organisms is a prerequisite to establishing accurate models of the kinetics and dynamics of drug action. Such methods would thus have far-reaching applications in drug development and molecular pharmacology. We recently presented one such technique based on fluorescence anisotropy, a spectroscopic method based on polarization light analysis and capable of measuring the binding interaction between molecules. Our technique allows the direct characterization of target engagement of fluorescently labeled drugs, using fluorophores with a fluorescence lifetime larger than the rotational correlation of the bound complex. Here we describe an optimized protocol for simultaneous dual-channel two-photon fluorescence anisotropy microscopy acquisition to perform drug-target measurements. We also provide the necessary software to implement stream processing to visualize images and to calculate quantitative parameters. The assembly and characterization part of the protocol can be implemented in 1 d. Sample preparation, characterization and imaging of drug binding can be completed in 2 d. Although currently adapted to an Olympus FV1000MPE microscope, the protocol can be extended to other commercial or custom-built microscopes.
- Published
- 2017
- Full Text
- View/download PDF
28. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis
- Author
-
Beldman, Thijs J., Senders, Max L., Alaarg, Amr, Pérez-Medina, Carlos, Tang, Jun, Zhao, Yiming, Fay, Francois, Deichmöller, Jacqueline, Born, Benjamin, Desclos, Emilie, van der Wel, Nicole N., Hoebe, Ron A., Kohen, Fortune, Kartvelishvily, Elena, Neeman, Michal, Reiner, Thomas, Calcagno, Claudia, Fayad, Zahi A., de Winther, Menno P. J., Lutgens, Esther, Mulder, Willem J. M., and Kluza, Ewelina
- Abstract
Hyaluronan is a biologically active polymer, which can be formulated into nanoparticles. In our study, we aimed to probe atherosclerosis-associated inflammation by using hyaluronan nanoparticles and to determine whether they can ameliorate atherosclerosis. Hyaluronan nanoparticles (HA-NPs) were prepared by reacting amine-functionalized oligomeric hyaluronan (HA) with cholanic ester and labeled with a fluorescent or radioactive label. HA-NPs were characterized in vitroby several advanced microscopy methods. The targeting properties and biodistribution of HA-NPs were studied in apoe–/–mice, which received either fluorescent or radiolabeled HA-NPs and were examined ex vivoby flow cytometry or nuclear techniques. Furthermore, three atherosclerotic rabbits received 89Zr-HA-NPs and were imaged by PET/MRI. The therapeutic effects of HA-NPs were studied in apoe–/–mice, which received weekly doses of 50 mg/kg HA-NPs during a 12-week high-fat diet feeding period. Hydrated HA-NPs were ca. 90 nm in diameter and displayed very stable morphology under hydrolysis conditions. Flow cytometry revealed a 6- to 40-fold higher uptake of Cy7-HA-NPs by aortic macrophages compared to normal tissue macrophages. Interestingly, both local and systemic HA-NP–immune cell interactions significantly decreased over the disease progression. 89Zr-HA-NPs-induced radioactivity in atherosclerotic aortas was 30% higher than in wild-type controls. PET imaging of rabbits revealed 6-fold higher standardized uptake values compared to the muscle. The plaques of HA-NP-treated mice contained 30% fewer macrophages compared to control and free HA-treated group. In conclusion, we show favorable targeting properties of HA-NPs, which can be exploited for PET imaging of atherosclerosis-associated inflammation. Furthermore, we demonstrate the anti-inflammatory effects of HA-NPs in atherosclerosis.
- Published
- 2017
- Full Text
- View/download PDF
29. URSULA MÄNNLE: GEHEN SIE ZUR BUNDESTAGSWAHL!
- Author
-
Reiner, Thomas
- Published
- 2017
30. DIE BUNDESTAGSWAHL 2017.
- Author
-
REINER, THOMAS
- Published
- 2017
31. In Vivo Imaging of GLP-1R with a Targeted BimodalPET/Fluorescence Imaging Agent.
- Author
-
Brand, Christian, Abdel-Atti, Dalya, Zhang, Yachao, Carlin, Sean, Clardy, Susan M., Keliher, Edmund J., Weber, Wolfgang A., Lewis, Jason S., and Reiner, Thomas
- Published
- 2014
- Full Text
- View/download PDF
32. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics
- Author
-
Zeglis, Brian M., Brand, Christian, Abdel-Atti, Dalya, Carnazza, Kathryn E., Cook, Brendon E., Carlin, Sean, Reiner, Thomas, and Lewis, Jason S.
- Abstract
Pretargeted PET imaging has emerged as an effective strategy for merging the exquisite selectivity of antibody-based targeting vectors with the rapid pharmacokinetics of radiolabeled small molecules. We previously reported the development of a strategy for the pretargeted PET imaging of colorectal cancer based on the bioorthogonal inverse electron demand Diels–Alder reaction between a tetrazine-bearing radioligand and a transcyclooctene-modified huA33 immunoconjugate. Although this method effectively delineated tumor tissue, its clinical potential was limited by the somewhat sluggish clearance of the radioligand through the gastrointestinal tract. Herein, we report the development and in vivo validation of a pretargeted strategy for the PET imaging of colorectal carcinoma with dramatically improved pharmacokinetics. Two novel tetrazine constructs, Tz-PEG7-NOTA and Tz-SarAr, were synthesized, characterized, and radiolabeled with 64Cu in high yield (>90%) and radiochemical purity (>99%). PET imaging and biodistribution experiments in healthy mice revealed that although 64Cu-Tz-PEG7-NOTA is cleared via both the gastrointestinal and urinary tracts, 64Cu-Tz-SarAr is rapidly excreted by the renal system alone. On this basis, 64Cu-Tz-SarAr was selected for further in vivo evaluation. To this end, mice bearing A33 antigen-expressing SW1222 human colorectal carcinoma xenografts were administered huA33-TCO, and the immunoconjugate was given 24 h to accumulate at the tumor and clear from the blood, after which 64Cu-Tz-SarAr was administered via intravenous tail vein injection. PET imaging and biodistribution experiments revealed specific uptake of the radiotracer in the tumor at early time points (5.6 ± 0.7 %ID/g at 1 h p.i.), high tumor-to-background activity ratios, and rapid elimination of unclicked radioligand. Importantly, experiments with longer antibody accumulation intervals (48 and 120 h) yielded slight decreases in tumoral uptake but also concomitant increases in tumor-to-blood activity concentration ratios. This new strategy offers dosimetric benefits as well, yielding a total effective dose of 0.041 rem/mCi, far below the doses produced by directly labeled 64Cu-NOTA-huA33 (0.133 rem/mCi) and 89Zr-DFO-huA33 (1.54 rem/mCi). Ultimately, this pretargeted PET imaging strategy boasts a dramatically improved pharmacokinetic profile compared to our first generation system and is capable of clearly delineating tumor tissue with high image contrast at only a fraction of the radiation dose created by directly labeled radioimmunoconjugates.
- Published
- 2015
- Full Text
- View/download PDF
33. Near-Infrared Fluorescent Probe for Imaging of Pancreatic β Cells.
- Author
-
Reiner, Thomas, Kohler, Rainer H., Liew, Chong Wee, Hill, Jonathan A., Gaglia, Jason, Kulkarni, Rohit N., and Weissleder, Ralph
- Published
- 2010
- Full Text
- View/download PDF
34. Ubiquitous Detection of Gram-Positive Bacteria with Bioorthogonal Magnetofluorescent Nanoparticles
- Author
-
Chung, Hyun Jung, Reiner, Thomas, Budin, Ghyslain, Min, Changwook, Liong, Monty, Issadore, David, Lee, Hakho, and Weissleder, Ralph
- Abstract
The ability to rapidly diagnose gram-positive pathogenic bacteria would have far reaching biomedical and technological applications. Here we describe the bioorthogonal modification of small molecule antibiotics (vancomycin and daptomycin), which bind to the cell wall of gram-positive bacteria. The bound antibiotics conjugates can be reacted orthogonally with tetrazine-modified nanoparticles, viaan almost instantaneous cycloaddition, which subsequently renders the bacteria detectable by optical or magnetic sensing. We show that this approach is specific, selective, fast and biocompatible. Furthermore, it can be adapted to the detection of intracellular pathogens. Importantly, this strategy enables detection of entire classes of bacteria, a feat that is difficult to achieve using current antibody approaches. Compared to covalent nanoparticle conjugates, our bioorthogonal method demonstrated 1–2 orders of magnitude greater sensitivity. This bioorthogonal labeling method could ultimately be applied to a variety of other small molecules with specificity for infectious pathogens, enabling their detection and diagnosis.
- Published
- 2011
- Full Text
- View/download PDF
35. Nanoparticle-Mediated Measurement of Target–Drug Binding in Cancer Cells
- Author
-
Ullal, Adeeti V., Reiner, Thomas, Yang, Katherine S., Gorbatov, Rostic, Min, Changwook, Issadore, David, Lee, Hakho, and Weissleder, Ralph
- Abstract
Responses to molecularly targeted therapies can be highly variable and depend on mutations, fluctuations in target protein levels in individual cells, and drug delivery. The ability to rapidly quantitate drug response in cells harvested from patients in a point-of-care setting would have far reaching implications. Capitalizing on recent developments with miniaturized NMR technologies, we have developed a magnetic nanoparticle-based approach to directly measure both target expression and drug binding in scant human cells. The method involves covalent conjugation of the small-molecule drug to a magnetic nanoparticle that is then used as a read-out for target expression and drug-binding affinity. Using poly(ADP-ribose) polymerase (PARP) inhibition as a model system, we developed an approach to distinguish differential expression of PARP in scant cells with excellent correlation to gold standards, the ability to mimic drug pharmacodynamics ex vivothrough competitive target–drug binding, and the potential to perform such measurements in clinical samples.
- Published
- 2011
- Full Text
- View/download PDF
36. Bioorthogonal Probes for Polo‐like Kinase 1 Imaging and Quantification
- Author
-
Budin, Ghyslain, Yang, Katherine S., Reiner, Thomas, and Weissleder, Ralph
- Abstract
Click inside: A nuclear protein target, polo‐like kinase 1 (PLK1) was imaged using a biocompatible bioorthogonal ligation between a specific drug and a fluorescent dye in live cells (see picture). Colocalization of the dye and the protein target was confirmed by antibody staining and by expressing a GFP construct of PLK1. The two‐step PLK1 imaging procedure was used to quantify PLK1 expression levels in cancer cell lines of various tissue origins.
- Published
- 2011
- Full Text
- View/download PDF
37. Bioorthogonal Probes for Polo‐like Kinase 1 Imaging and Quantification
- Author
-
Budin, Ghyslain, Yang, Katherine S., Reiner, Thomas, and Weissleder, Ralph
- Abstract
Ein Zellkernprotein, die Polo‐like‐Kinase 1 (PLK1), wurde mithilfe einer biokompatiblen bioorthogonalen Ligation zwischen einem spezifischen Wirkstoff und einem Fluoreszenzfarbstoff in lebenden Zellen abgebildet. Die Colokalisation des Farbstoffs und Proteins wurde durch Antikörperfärbung und Expression eines GFP‐Konstrukts der PLK1 bestätigt. Die zweistufige Prozedur wurde genutzt, um Expressionsspiegel von PLK1 in Krebszell‐Linien aus verschiedenen Geweben zu quantifizieren.
- Published
- 2011
- Full Text
- View/download PDF
38. Towards Quantitative Catalytic Lignin Depolymerization
- Author
-
Roberts, Virginia. M., Stein, Valentin, Reiner, Thomas, Lemonidou, Angeliki, Li, Xuebing, and Lercher, Johannes A.
- Abstract
The products of base‐catalyzed liquid‐phase hydrolysis of lignin depend markedly on the operating conditions. By varying temperature, pressure, catalyst concentration, and residence time, the yield of monomers and oligomers from depolymerized lignin can be adjusted. It is shown that monomers of phenolic derivatives are the only primary products of base‐catalyzed hydrolysis and that oligomers form as secondary products. Oligomerization and polymerization of these highly reactive products, however, limit the amount of obtainable product oil containing low‐molecular‐weight phenolic products. Therefore, inhibition of concurrent oligomerization and polymerization reactions during hydrothermal lignin depolymerization is important to enhance product yields. Applying boric acid as a capping agent to suppress addition and condensation reactions of initially formed products is presented as a successful approach in this direction. Combination of base‐catalyzed lignin hydrolysis with addition of boric acid protecting agent shifts the product distribution to lower molecular weight compounds and increases product yields beyond 85 %.
- Published
- 2011
- Full Text
- View/download PDF
39. Synthesis and In Vivo Imaging of a 18F‐Labeled PARP1 Inhibitor Using a Chemically Orthogonal Scavenger‐Assisted High‐Performance Method
- Author
-
Reiner, Thomas, Keliher, Edmund J., Earley, Sarah, Marinelli, Brett, and Weissleder, Ralph
- Abstract
Pedal to the metal: The catalyst‐free Diels–Alder cycloaddition of trans‐cyclooctene and tetrazine was used to quickly and selectively generate an 18F‐labeled AZD2281 derivative from a tetrazine‐linked precursor. The probe was tested in biological assays, and its targeted accumulation was confirmed in vivo. This protocol allows the parallel synthesis of a library of potential PET imaging agents in a short time, thus increasing the efficiency of lead compound development.
- Published
- 2011
- Full Text
- View/download PDF
40. Synthese und In‐vivo‐Bildgebung eines 18F‐markierten PARP1‐ Inhibitors mithilfe eines chemisch orthogonalen, Abfangreagens‐ gestützten Hochdurchsatzverfahrens
- Author
-
Reiner, Thomas, Keliher, Edmund J., Earley, Sarah, Marinelli, Brett, and Weissleder, Ralph
- Abstract
Schneller zum Ziel:Ein durch katalysatorfreie Diels‐Alder‐Cycloaddition zwischen trans‐Cycloocten und Tetrazin schnell und selektiv aus seiner Tetrazin‐konjugierten Vorstufe hergestelltes 18F‐markiertes AZD2281‐Derivat wurde in biologischen Assays erfolgreich getestet, und seine gezielte Anreicherung wurde in vivo nachgewiesen. Das Verfahren steigert durch die Parallelsynthese potenzieller PET‐Tracer die Effizienz der Leitstrukturentwicklung.
- Published
- 2011
- Full Text
- View/download PDF
41. PET Imaging of DNA Damage Response following 225Ac-radioimmunotherapy in a Pancreatic Ductal Adenocarcinoma Mouse Model.
- Author
-
Poty, Sophie, Knight, James C., Donabedian, Patrick, Mandleywala, Komal, Cornelissen, Bart, Reiner, Thomas, and Lewis, Jason S.
- Subjects
DNA analysis ,CONFERENCES & conventions ,ANIMAL experimentation ,IMMUNOTHERAPY ,PANCREATIC tumors ,POSITRON emission tomography - Published
- 2019
- Full Text
- View/download PDF
42. Ubiquitin Metabolism Affects Cellular Response to Volatile Anesthetics in Yeast
- Author
-
Wolfe, Darren, Reiner, Thomas, Keeley, Jessica L., Pizzini, Mark, and Keil, Ralph L.
- Abstract
ABSTRACTTo investigate the mechanism of action of volatile anesthetics, we are studying mutants of the yeast Saccharomyces cerevisiaethat have altered sensitivity to isoflurane, a widely used clinical anesthetic. Several lines of evidence from these studies implicate a role for ubiquitin metabolism in cellular response to volatile anesthetics: (i) mutations in the ZZZ1gene render cells resistant to isoflurane, and the ZZZ1gene is identical toBUL1(binds ubiquitin ligase), which appears to be involved in the ubiquitination pathway; (ii) ZZZ4, which we previously found is involved in anesthetic response, is identical to the DOA1/UFD3gene, which was identified based on altered degradation of ubiquitinated proteins; (iii) analysis of zzz1? zzz4?double mutants suggests that these genes encode products involved in the same pathway for anesthetic response since the double mutant is no more resistant to anesthetic than either of the single mutant parents; (iv) ubiquitin ligase (MDP1/RSP5) mutants are altered in their response to isoflurane; and (v) mutants with decreased proteasome activity are resistant to isoflurane. TheZZZ1and MDP1/RSP5gene products appear to play important roles in determining effective anesthetic dose in yeast since increased levels of either gene increases isoflurane sensitivity whereas decreased activity decreases sensitivity. Like zzz4strains, zzz1mutants are resistant to all five volatile anesthetics tested, suggesting there are similarities in the mechanisms of action of a variety of volatile anesthetics in yeast and that ubiquitin metabolism affects response to all the agents examined.
- Published
- 1999
- Full Text
- View/download PDF
43. Ubiquitin Metabolism Affects Cellular Response to Volatile Anesthetics in Yeast
- Author
-
Wolfe, Darren, Reiner, Thomas, Keeley, Jessica L., Pizzini, Mark, and Keil, Ralph L.
- Abstract
To investigate the mechanism of action of volatile anesthetics, we are studying mutants of the yeast Saccharomyces cerevisiaethat have altered sensitivity to isoflurane, a widely used clinical anesthetic. Several lines of evidence from these studies implicate a role for ubiquitin metabolism in cellular response to volatile anesthetics: (i) mutations in the ZZZ1gene render cells resistant to isoflurane, and the ZZZ1gene is identical to BUL1(binds ubiquitin ligase), which appears to be involved in the ubiquitination pathway; (ii) ZZZ4, which we previously found is involved in anesthetic response, is identical to the DOA1/UFD3gene, which was identified based on altered degradation of ubiquitinated proteins; (iii) analysis of zzz1Δ zzz4Δdouble mutants suggests that these genes encode products involved in the same pathway for anesthetic response since the double mutant is no more resistant to anesthetic than either of the single mutant parents; (iv) ubiquitin ligase (MDP1/RSP5) mutants are altered in their response to isoflurane; and (v) mutants with decreased proteasome activity are resistant to isoflurane. The ZZZ1and MDP1/RSP5gene products appear to play important roles in determining effective anesthetic dose in yeast since increased levels of either gene increases isoflurane sensitivity whereas decreased activity decreases sensitivity. Like zzz4strains, zzz1mutants are resistant to all five volatile anesthetics tested, suggesting there are similarities in the mechanisms of action of a variety of volatile anesthetics in yeast and that ubiquitin metabolism affects response to all the agents examined.
- Published
- 1999
- Full Text
- View/download PDF
44. PET Imaging of DNA Damage Response following 225Ac-radioimmunotherapy in a Pancreatic Ductal Adenocarcinoma Mouse Model.
- Author
-
Poty, Sophie, Knight, James C., Donabedian, Patrick, Mandleywala, Komal, Cornelissen, Bart, Reiner, Thomas, and Lewis, Jason S.
- Subjects
BIOLOGICAL models ,CONFERENCES & conventions ,DNA ,PANCREATIC tumors ,RADIOIMMUNOTHERAPY ,POSITRON emission tomography - Published
- 2019
- Full Text
- View/download PDF
45. Not-for-Profit Organizations in the Soviet Union: Turning On Some Lights
- Author
-
Reiner, Thomas A.
- Abstract
This article describes the fledgling state and growth of not-for-profit orga nizations in the Soviet Union. The buoyant reappearance of this sector can be seen as a response to the legitimized recognition of gaps in service delivery at a time when social, political, and economic changes under perestroika create openings for new initiatives, which challenge the mono lithic system in place. As such, not-for-profits reflect state failure and, at the same time, tentative movements toward a civic society. Some continuity with prerevolutionary practices and institutions is noted.
- Published
- 1991
- Full Text
- View/download PDF
46. The Not-for-Profit Sector in Stable and Growing Metropolitan Regions
- Author
-
Wolpert, Julian and Reiner, Thomas
- Abstract
A regional focus on not-for-profit organizations leads to a better understanding of the not-for-profit (NFP) sector, adding to the insights coming from national studies. The research reported here, focusing on the Philadelphia, Minneapolis-St. Paul, Houston, and Los Angeles areas, shows major contrasts in funding and in certain structural features of the NFPs. For example, the NFP share of the service sector in Philadelphia is three times the share in Houston, pointing to the importance of an early start in determining NFP representation. The impact of the 1973-1974 recession provides some clues to the importance of a diversified funding base and the consequences of business cycles on NFP expenditures for program-related activities.
- Published
- 1985
- Full Text
- View/download PDF
47. Welfare differences within a nation
- Author
-
Reiner, Thomas A.
- Published
- 1974
- Full Text
- View/download PDF
48. Organizational Survival in an Environment of Austerity
- Author
-
Reiner, Thomas A.
- Abstract
In the turbulent and competitive environment of contemporary social service, government may seek to transfer important program func tions to nonprofit organizations. Subjected to management control mechanisms, such as caps, and expectations of self-sufficiency, nonprofits often seek to establish an institutional entitlement for continuing support. Aspects of the complex relationship between government and nonprofits are explored in a case study of New York state's Neighborhood Preservation Program.
- Published
- 1989
- Full Text
- View/download PDF
49. A Choice Theory of Planning
- Author
-
Davidoff, Paul and Reiner, Thomas
- Abstract
Planning is defined as the process for determining appropriate future action. The choices which thus constitute the planning process are made at three levels: first, the selection of ends and criteria; second, the identification of a set of alternatives consistent with these general prescriptives, and the selection of a desired alternative; and third, guidance of action toward determined ends. Values are inescapable elements of any rational decision-making process, or any exercise of choice. Since choice permeates the whole planning sequence, a clear notion of the ways in which choices are made, and of the ends pursued, must lie at the heart of the planner's task. Explication of all such determinations reduces arbitrariness. The theory presented is a general one, applying to all fields, and is not restricted to planning in an urban context.
- Published
- 1962
- Full Text
- View/download PDF
50. Recent Books on Resources
- Author
-
Reiner, Thomas
- Published
- 1964
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.